Jc Yao

About Jc Yao

Proven digital leader in pharma with a track record of transforming drug discovery and development through cutting-edge innovation. As one of the first digital leaders embedded in the biomarker strategy of Keytruda - the best-selling oncology drug, I’ve leveraged AI-powered solutions to drive measurable business and scientific impact across therapies and vaccines at Merck & Co. I am driving digital and AI initiatives across research and manufacturing at Alnylam to advance the science of RNAi therapeutics and bring transformative medicines to patients worldwide.

Experience

1. Vice President - Research and Early Development & Technical Operations and Quality Technology

   Alnylam Pharmaceuticals

   Sep 2025 — Present · Cambridge, MA, US

Education

• The University of Texas at Austin

  Doctor of Philosophy (Ph.D.), Molecular Biology (Bioinformatics Track)

  2003 — 2009

• The University of Texas at Austin

  Master of Science (M.S.), Statistics

  2005 — 2007

• The University of Hong Kong

  Master of Philosophy (M.Phil.), Biomedical Engineering

  2001 — 2003

• Southeast University

  Bachelor of Engineering (B.E.), Biomedical Engineering

  1996 — 2000

Skills

• Bioinformatics
• Genomics
• Sequencing
• Statistics
• Genetics
• Dna Sequencing
• Computational Biology
• Data Analysis
• Perl
• Biostatistics
• Algorithms
• Science
• Data Mining
• Cancer
• Machine Learning
• Biomarker Discovery
• Drug Development
• Statistical Modeling
• Rnaseq
• Biomedical Engineering
• Gene Expression
• Mathematical Modeling
• Databases
• Dna
• Biomarkers
• Molecular Genetics
• Rt-Pcr
• Systems Biology
• Linux
• High Performance Computing
• Big Data
• Software Development
• Project Management
• Product Development
• Product Management
• Clinical Trials